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Cellular mRNAs exist in messenger ribonucleopro-
tein (mRNP) complexes, which undergo transitions
during the lifetime of the mRNAs and direct posttran-
scriptional gene regulation. A final posttranscrip-
tional step in gene expression is the turnover of the
mRNP, which involves degradation of the mRNA
and recycling of associated proteins. How tightly
associated protein components are released from
degrading mRNPs is unknown. Here, we demon-
strate that the ATPase activity of the RNA helicase
Upf1 allows disassembly of mRNPs undergoing
nonsense-mediated mRNA decay (NMD). In the
absence of Upf1 ATPase activity, partially degraded
NMD mRNA intermediates accumulate in complex
with NMD factors and concentrate in processing
bodies. Thus, disassembly and completion of
turnover of mRNPs undergoing NMD requires ATP
hydrolysis by Upf1. This uncovers a previously unap-
preciated and potentially regulated step in mRNA
decay and raises the question of how other mRNA
decay pathways release protein components of
substrate mRNPs.
INTRODUCTION
mRNA decay is a critical step in the regulation of gene expres-
sion. The stability of mRNAs can vary by orders of magnitude
and is dictated by the composition of the messenger ribonucleo-
protein (mRNP) (Balagopal and Parker, 2009; Moore, 2005). How
decay-promoting mRNP components activate mRNA turnover is
poorly understood. Several studies have shown evidence that
the recruitment of mRNA decay enzymes is a critical step in
mRNA turnover (Cho et al., 2009; Gherzi et al., 2004; Lykke-An-
dersen and Wagner, 2005; Moraes et al., 2006). Yet, it is
unknown how recruited mRNA decay enzymes access the
mRNA through stably associated protein components of the938 Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc.mRNP. In an analogous manner, early models for transcription
activation focused on the recruitment of RNA polymerase,
whereas later studies demonstrated the importance of chro-
matin modification and remodeling (Campos and Reinberg,
2009). Does the mRNP constitute an obstacle to mRNA turnover
as chromatin does to transcription?
Evidence primarily from the yeast Saccharomyces cerevisiae
suggests that mRNA degradation generally initiates with removal
of the mRNA poly(A)-tail by deadenylases, which stimulates
either mRNA decapping and subsequent 50-to-30 exonucleolytic
decay by Xrn1 (Doma and Parker, 2007; Garneau et al., 2007) or
degradation in the 30-to-50 direction by the exosome (Schmid and
Jensen, 2008). In addition, some mRNA decay pathways trigger
endonucleolytic cleavage followed by 30-to-50 and 50-to-30 exo-
nucleolytic decay of the mRNA fragments by the exosome and
Xrn1, respectively (Wilusz, 2009). However, although much has
been learned about the enzymes that degrademRNAs, it remains
unknown how the mRNA decay enzymes negotiate the mRNP.
Nonsense-mediatedmRNAdecay (NMD) is anmRNA turnover
pathway that targetsmRNAswith premature translation termina-
tion codons (PTCs) for rapid degradation, thereby suppressing
protein expression from aberrant mRNAs, as well as a subset
of normal NMD-regulated mRNAs (Amrani et al., 2006; Behm-
Ansmant et al., 2007; Chang et al., 2007; Isken and Maquat,
2007; Mu¨hlemann et al., 2008; Rebbapragada and Lykke-
Andersen, 2009). How a termination codon is recognized as
premature remains under investigation, but it appears to occur
when a ribosome terminates translation sufficiently upstream
of a normal 30 UTR to prevent 30 UTR-associated proteins,
including cytoplasmic poly(A)-binding protein (PABPC), from
stimulating a proper termination event (Amrani et al., 2006; Mu¨h-
lemann et al., 2008; Rebbapragada and Lykke-Andersen, 2009).
This initiates the assembly of anNMDmRNPwith the recruitment
of the NMD factor Upf1 and its cofactors Upf2 and Upf3 to the
terminating ribosome. In vertebrates, NMD is strongly stimulated
when an exon junction complex (EJC), which interacts with the
Upf complex, is positioned downstream of the termination event
(Behm-Ansmant et al., 2007; Isken and Maquat, 2007; Moore
and Proudfoot, 2009; Mu¨hlemann, 2008; Rebbapragada and
Lykke-Andersen, 2009). In metazoans, the NMDmRNP is further
modulated by a phosphorylation-dephosphorylation cycle of
Upf1 mediated by the kinase Smg1 and by protein phosphatase
2A in association with the NMD factors Smg5 and Smg7 (Fuku-
hara et al., 2005; Glavan et al., 2006; Ohnishi et al., 2003; Page
et al., 1999; Yamashita et al., 2001). The assembled NMD
mRNP subsequently recruits mRNA decay enzymes to initiate
mRNA degradation. Depending on the specific organism, decay
can initiate by decapping, deadenylation, and/or endonucleo-
lytic cleavage (Mu¨hlemann and Lykke-Andersen, 2010). Recent
evidence suggests that in human and Drosophila cells, decay
of the NMD substrate is primarily initiated by endonucleolytic
cleavage by the NMD factor Smg6 followed by 30-to-50 and
50-to-30 exonucleolytic decay of the mRNA fragments by the
exosome and Xrn1, respectively (Gatfield and Izaurralde, 2004;
Glavan et al., 2006; Huntzinger et al., 2008; Eberle et al., 2009).
However, it remains an unresolved question how the NMD
factors are recycled from the degrading NMD mRNP. Are they
released by the activity of the mRNA decay enzymes or do
they require active removal prior to or during mRNA decay?
A central component of the NMD pathway, Upf1, belongs to
helicase superfamily 1 and shows RNA-dependent ATPase
and 50-to-30 RNA helicase activities in vitro (Bhattacharya et al.,
2000; Chamieh et al., 2008; Cheng et al., 2007; Czaplinski
et al., 1995). The ATPase activity of Upf1 is critical to the NMD
pathway (Kashima et al., 2006; Weng et al., 1996a); however,
its specific role remains unresolved. Although helicases were
first described as ATPases that unwind polynucleotide duplexes,
several helicases of superfamily 2 have more recently been
shown to function as RNPases that promote ATP-dependent
mRNP remodeling in the absence of double-stranded RNA (Fair-
man et al., 2004; Jankowsky et al., 2001). Early studies impli-
cated the Upf1 ATPase at the translation termination step of
yeast NMD (Weng et al., 1998), but more recent observations
in yeast show that ATPase-deficient mutant Upf1 accumulates
with NMD substrates in cytoplasmic mRNP granules called pro-
cessing bodies (PBs) (Cheng et al., 2007; Sheth and Parker,
2006). This suggests that the failure of Upf1 to hydrolyze ATP
causes the accumulation of an NMD mRNP in association with
mRNA decay factors. Here, we demonstrate that the Upf1
ATPase stimulates the removal and recycling of NMD factors
from mRNPs targeted for NMD. This is required for the comple-
tion of exonucleolytic decay of the NMD substrate. In the
absence of Upf1 ATPase activity, NMD factors become trapped
with partially degraded 30 NMD mRNP intermediates. This
demonstrates the importance of mRNP disassembly in mRNA
turnover, and raises the questions of whether this is a regulated
step in NMD and to what extent mRNP disassembly is a critical
step in other mRNA decay pathways.
RESULTS
The 30 Fragment Generated upon Endonucleolytic
Cleavage of NMD mRNA Substrates Accumulates
in the Presence of ATPase-Deficient Upf1
To investigate the function of Upf1 ATPase activity in NMD, we
tested the effect of impairing human (h)Upf1 ATP binding
and hydrolysis on the degradation of NMD substrate mRNAs.
A b-globin mRNA with a PTC at position 39 (b-39) was subjectedto pulse-chasemRNA decay assays in humanHeLa Tet-off cells,
in which endogenous hUpf1 was depleted with an siRNA and
replaced with exogenous siRNA-resistant wild-type hUpf1
(hUpf1R), or mutants thereof that fail to hydrolyze (hUpf1 DEAAR)
or fail to bind (hUpf1 K498AR) ATP (Bhattacharya et al., 2000;
Cheng et al., 2007). As expected, the b-39 NMD substrate is
significantly more stable in the presence of hUpf1 ATPase
mutants than with wild-type hUpf1 (Figure 1A, top panel; see
band labeled b-39). Surprisingly, however, a fast migrating
mRNA species (indicated by an arrow in Figure 1A) accumulates
when hUpf1 ATPase mutant proteins are expressed, but is not
observed in the presence of wild-type hUpf1 (Figure 1A, top
panel; quantified in Figure 1B). This product corresponds to
the 30 fragment of the NMD substrate following endonucleolytic
cleavage by Smg6, because it is not observed with a probe
specific to the 50 end of b-globin mRNA and is strongly reduced
under Smg6 knockdown conditions (see Figures S1A–S1C
available online). In contrast to the 30 fragment, no 50 fragment
was detectable upon hUpf1 ATPase mutant expression (Fig-
ure 1A and Figure S1D). Thus, ATPase-deficient hUpf1 allows
endonucleolytic cleavage of the NMD substrate, followed by
exonucleolytic decay of the resulting 50 product, but impairs
the degradation of the 30 product.
How can the failure of hUpf1 to bind or to hydrolyze ATP
specifically affect the NMD substrate 30 decay intermediate?
One possibility is that the 30 intermediate requires Upf1
ATPase activity to be accessible to Xrn1, the 50-to-30 exonu-
clease that normally degrades this fragment (Gatfield and Izaur-
ralde, 2004; Huntzinger et al., 2008; Eberle et al., 2009). If so, the
same fragment should accumulate upon depletion of Xrn1 in the
presence of both wild-type and ATPase-deficient hUpf1. To test
this idea, Xrn1 was depleted with siRNAs that modestly (Xrn1 #1)
or strongly (Xrn1 #2) reduce Xrn1 levels (Figure 1C), and the
effect on the decay of the b-39 mRNA was monitored. As seen
in Figure 1A (middle panel), when Xrn1 is modestly depleted,
the b-39 mRNA 30 fragment accumulates strongly in the pres-
ence of ATPase-deficient hUpf1, but not with wild-type hUpf1.
Only when Xrn1 is strongly depleted does the 30 b-39mRNA frag-
ment accumulate in cells expressing wild-type hUpf1 (Figure 1A,
bottom panel; quantified in Figure 1B). However, even under
these conditions, the resulting 30 mRNA fragment is rapidly
degraded with an apparent half-life 2–4-fold shorter than that
observed when hUpf1 ATPase mutants are expressed. A similar
pattern of NMD substrate 30 fragment accumulation was
observed when a different NMD substrate, GPx1-46, was tested
(Figure 1D). These observations are not a result of globally
impaired Xrn1 activity, because Xrn1-mediated degradation of
the 30 fragment of a b-globin reporter mRNA subjected to endo-
nucleolytic cleavage by endogenous let-7 microRNA is not
impaired in the presence of ATPase-deficient hUpf1 (Figure S1E).
Thus, although it is well established that the Upf1 protein plays
a key role in the recognition step of NMD (Amrani et al., 2006;
Kashima et al., 2006; Mu¨hlemann et al., 2008; Ohnishi et al.,
2003; Rebbapragada and Lykke-Andersen, 2009), the observa-
tions shown here suggest that the ATPase activity of Upf1 is
required at a later step in NMD (Figure 1). Consistent with this,
when mRNA decay is initiated by tethered hUpf1, thereby by-
passing the Upf1 recruitment step of NMD (Lykke-AndersenCell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc. 939
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Figure 1. The 30 Fragment Generated upon Endonucleolytic Cleavage of NMD Substrates Accumulates When hUpf1 Fails to Hydrolyze ATP
(A) Northern blots showing the decay of b-globin mRNA with a PTC at position 39 (b-39) in HeLa Tet-off cells depleted of endogenous hUpf1 using an siRNA and
expressing exogenous siRNA-resistant wild-type hUpf1 (hUpf1R), or hUpf1 ATPase (hUpf1 DEAAR) or ATP-binding (hUpf1 K498AR) mutants. siRNAs targeting
Xrn1 were included in the experiments in the bottom two panels. Time points above each lane represent the elapsed time following transcriptional shut-off of
b-39 mRNA by tetracycline addition. The 30 endonucleolytic cleavage fragment of b-39 (b-39 30 ) is indicated by arrows.
(B) Quantification showing the percentage b-39 30 mRNA fragment of total b-39 mRNA immediately after the transcriptional pulse (t = 0) for each condition
indicated. Percentages and standard deviations are calculated from three experiments.
(C) Western blots showing Xrn1 levels in HeLa Tet-off cells treated with a control siRNA (FLuc) (100%, 50%, or 20% total protein was loaded) or with the two Xrn1
siRNAs used in (A) (Xrn1 #1 or Xrn1 #2). hUpf3b served as a loading control.
(D) Northern blots showing GPx1 mRNA with a PTC at position 46 (GPx1-46) after a 6 hr transcriptional pulse in HeLa Tet-off cells treated as described in (A).
See also Figure S1.et al., 2000), ATP binding-deficient hUpf1 causes accumulation
of a 30 fragment that is not observed with tethered wild-type
Upf1 unless Xrn1 is efficiently knocked down (Figure S1F).
ATPase-Deficient hUpf1 Accumulates on the 30 NMD
Intermediate
How does the Upf1 ATPase stimulate degradation of the 30 NMD
fragment by Xrn1? One possibility is that the Upf1 ATPase
triggers removal of protein from the 30 NMDmRNP intermediate,
thereby allowing access for Xrn1. If so, it is predicted that wild-
type hUpf1 should cycle off the 30 NMD intermediate, whereas
ATPase-deficient hUpf1 should fail to do so. This ideawas tested
using hUpf1 immunoprecipitation (IP) followed by Northern940 Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc.blotting for associated NMD substrate mRNA under strong
Xrn1 knock-down conditions. As seen in Figure 2A, both wild-
type and mutant hUpf1 proteins associate with full-length b-39
NMD substrate produced by a short transcriptional pulse (lanes
6–8). However, the association of the accumulating 30 b-39
fragment with ATPase-deficient hUpf1 is strongly enhanced
(4.1-fold relative to full-length b-39) as compared with wild-
type hUpf1 (Figure 2A; compare lanes 7 and 8 to lane 6; band
marked by arrow). These interactions occur in the cell and do
not form after cell lysis, because b-39 mRNA does not copurify
with wild-type ormutant hUpf1 when expressed in separate cells
and combined during cell lysis (Figure 2B; compare lanes 6 to 5
and lanes 12 to 11), and the mRNA substrate does not copurify
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Figure 2. The 30 NMD Endonucleolytic Cleavage Fragment Is Stuck with ATPase-Deficient Upf1 and Is Resistant to 50-to-30 Exonucleolytic
Decay In Vitro
(A) Northern blot for b-39 mRNA from pellet (lanes 5-8) or 5% of total extract (lanes 1–4) fractions from anti-myc IP assays from cells transiently expressing
myc-tagged hUpf1 proteins indicated on the top or no exogenous protein (none). Cells were treated with Xrn1 #2 siRNA to promote the accumulation of the
b-39 mRNA 30 fragment.
(B) Same as (A), but b-39mRNAwas expressed either in the same cells as wild-type (WT) or DEAAmutant (DE) hUpf1 (lanes 2, 5, 8, and 11), or in different cells and
mixed prior to extract preparation (lanes 3, 6, 9, and 12). Lanes 1–3 and 7–9: 5% of total extracts; lanes 4–6 and 10–12: IP pellets. Lanes 1, 4, 7, and 10 are from
cells not expressing Myc-hUpf1. All cells were treated with Xrn1 #2 siRNA to promote the accumulation of the b-39 mRNA 30 fragment.
(C) Northern blots showing in vitro Terminator-mediated decay of b-39 30 mRNA fragment from extracts (left panels) or total RNA (right panels) from HeLa Tet-off
cells depleted of endogenous hUpf1 using an siRNA and expressing exogenous siRNA-resistant wild-type hUpf1 (hUpf1R) or hUpf1 ATPase mutants. An siRNA
targeting Xrn1 (Xrn1 #2) was included in all experiments. Time points above each lane represent the time of Terminator incubation. Bottom panels: incubation in
the absence of Terminator.
(D) Quantification for each of the experiments in (C). Percentages and standard deviations are calculated from three experiments.
See also Figure S2.with the antibody in the absence of exogenous hUpf1 (Figure 2A,
lane 5, and Figure 2B, lanes 4 and 10). These observations
are consistent with the idea that ATPase activity is not critical
for recruitment of hUpf1 to the NMD substrate, but is required
for the release of hUpf1 from the 30 fragment that forms after
initiation of mRNA decay.The 30 NMDmRNP Fragment Generated in the Presence
of ATPase-Deficient Upf1 Is Resistant to 50-to-30
Exonucleolytic Decay In Vitro
If the 30 NMD intermediate that forms in the presence of hUpf1
ATPase mutants is resistant to Xrn1 because of a failure in
mRNP disassembly, it should become sensitive to 50-to-30Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc. 941
exonucleolytic decay if protein is removed from the mRNP. To
test this idea in vitro, b-39 mRNA was expressed along with
exogenous wild-type or ATPase-deficient hUpf1 proteins in
HeLa Tet-off cells depleted for endogenous Xrn1 and hUpf1.
Cells were subsequently permeabilized, and the resulting cell
extracts were incubated with the Terminator enzyme, a commer-
cially available 50-to-30 exonuclease. As seen in Figure 2C (left
panels), although the 30 NMD mRNA fragment that accumulates
as a result of Xrn1 knock-down in the presence of wild-type
hUpf1 is degraded efficiently (t1/2 z 18 min), a large fraction
(60%–70%) of the same RNA produced in cells expressing
ATPase-deficient Upf1 proteins is highly resistant to 50-to-30 exo-
nucleolytic decay (quantified in Figure 2D, top panel). In contrast,
when mRNPs were disrupted and protein removed from the cell
extracts by phenol extraction prior to incubation with the
nuclease, the 30 NMD fragment is degraded efficiently regardless
of the ability of Upf1 to hydrolyze ATP (Figure 2C, right panels;
quantified in Figure 2D, bottom panel). As expected, full-length
b-39 mRNA is resistant to the Terminator enzyme, which is
specific for 50 monophosphate-containing RNA and thus does
not target capped RNA (Figure 2C; upper bands), and the 30 frag-
ment does not degrade in the absence of Terminator (bottom
panels). When the endonuclease RNase A was used in place of
Terminator, all RNAs rapidly degrade (Figure S2). Thus, when
Upf1 fails to hydrolyze ATP, the 30 NMD fragment generated by
Smg6-mediated endonucleolytic cleavage becomes trapped in
an mRNP that includes hUpf1 and is resistant to exonucleolytic
decay from the 50 end.
The 30 NMD Intermediate Accumulates in PBs
in the Presence of ATPase-Deficient Upf1
Anumberof studieshavedemonstrated that cytoplasmicmRNPs
that accumulate in association with 50-to-30 mRNA decay
complexes concentrate in PBs (Eulalio et al., 2007; Franks and
Lykke-Andersen, 2008; Parker and Sheth, 2007). Thus, if hUpf1
ATPase activity is critical for NMD mRNP disassembly during
mRNA decay, it is predicted that the NMD intermediate should
accumulate in PBs when hUpf1 fails to hydrolyze ATP. Indeed,
as seen in the fluorescence in situ hybridization (FISH) assays in
Figure 3A, both b-39 (panels 2 and 3) and GPx1-46 (panels 5
and 6) mRNAs accumulate strongly in PBs in the presence of
ATPase-deficient hUpf1, but are rarely detected when wild-type
hUpf1 is expressed (panels 1 and 4). This finding is consistent
with previous observations in yeast (Sheth and Parker, 2006). In
contrast, wild-type b-globin mRNA accumulated only at very
low levels in PBs upon mutant hUpf1 expression (Figure S3).
We next used individual probes hybridizing to different regions
along the b-globin mRNA to ask which part of the NMD substrate
accumulates in PBs. Remarkably, although the region 30 of the
PTC of b-39mRNAwas readily detectable in PBs in the presence
of ATPase-deficient hUpf1, the 50 end remained completely
undetectable in PBs (Figure 3B, compare panels 4 and 5 with
panels 1 and 2; quantifications below), despite the fact that the
full-length mRNA under these conditions is 6–10-fold more
abundant than the 30 fragment (Figures 1A and 1B). A probe
that hybridizes across the mapped Smg6 endonucleolytic
cleavage sites (Eberle et al., 2009) modestly detects the mRNA
in PBs (panel 3). The observed differences in PB detection are942 Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc.not due to different efficiencies of the FISH probes, because,
in contrast to the b-39 mRNA, each FISH probe equally detected
in PBs a b-globin mRNA targeted for the ARE-mRNA decay
pathway (b-ARE) (compare panels 6–10 with panels 1–5; quanti-
fications below). The observed localization pattern is not unique
to the b-39 mRNA, as in the presence of ATPase-deficient hUpf1
the 30 end of an unrelated NMD substrate, GPx1-46, could also
be observed in PBs in contrast to its 50 end (Figure 3C). Thus,
the 30 NMD mRNA decay intermediate that accumulates when
Upf1 fails to hydrolyze ATP forms an mRNP that concentrates
in PBs.
Multiple NMDFactors Accumulate in PBs in theAbsence
of Upf1 ATPase Activity
What are the protein components of the accumulating 30 NMD
mRNP intermediate? On the basis of the observations above,
such proteins are predicted (1) to accumulate in PBs in the pres-
ence of ATPase-deficient Upf1, (2) to copurify more strongly with
ATPase-deficient Upf1 than with wild-type Upf1 in coimmuno-
precipitation (co-IP) assays, and (3) to copurify the NMD mRNA
30 fragment when immunoprecipitated. We tested these predic-
tions for multiple NMD factors. Consistent with hUpf1 being part
of the 30 NMDmRNPandwith previous observations in yeast and
human cells (Sheth and Parker, 2006; Cheng et al., 2007; Cho
et al., 2009; Stalder and Muhlemann, 2009), indirect immunoflu-
orescence assays revealed that ATP binding- and ATPase-
deficient mutant hUpf1 proteins, but not wild-type hUpf1, accu-
mulate strongly in PBs (Figure 4, compare panels 4, 7, 10, 13 to
panel 1). This is consistent with the observation that ATPase
activity is required for the release of hUpf1 from the degrading
NMD mRNP (Figure 2A).
What about other NMD factors? Remarkably, exogenously ex-
pressed ATPase-deficient hUpf1 (Figure 5A), but not wild-type
hUpf1 (Figure 5B), induces strong accumulation of endogenous
Smg5, Smg6, and Smg7 in PBs (panels 4, 7, and 10; transfected
cells identified by the coexpression of NLS-DsRed are marked
by arrowheads) but has no observable effect on the localization
of an unrelated RNA-binding protein, HuR (panel 28). Smg1,
hUpf2, and the EJC components Y14 and eIF4A3moremodestly
accumulate in PBs (panels 13, 16, 19, and 22), whereas hUpf3a
and hUpf3bwere only rarely observed in PBs (unpublished data).
None of the NMD factors localized strongly in PBs in untrans-
fected cells (Figures 5A and 5B; cells not indicated by arrow-
heads), which in all cases looked similar to those expressing
exogenous wild-type hUpf1 (Figure 5B). Similarly to NMD
factors, Xrn1 consistently showed enhanced accumulation in
PBs in cells expressing ATPase-deficient hUpf1 (Figure 5A,
panel 25; cell marked by arrowhead) as compared with cells
expressing exogenous wild-type hUpf1 (Figure 5B, panel 25) or
no exogenous hUpf1 (Figures 5A and 5B, panel 25; unmarked
cells). Thus, multiple NMD factors and Xrn1 coaccumulate with
NMD intermediates in PBs in the presence of ATPase-deficient
hUpf1 (Figure 5).
ATPase-Deficient hUpf1 Shows Enhanced
Copurification with Multiple NMD Factors
We next tested the prediction that proteins that require Upf1
ATPase activity for release from the NMDmRNP should copurify
AB
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Figure 3. The 30 NMD Intermediate Accumulates in PBs in the Presence of ATPase-Deficient hUpf1
(A–C) FISH assays showing localization of b-39, b-ARE and GPx1-46 mRNAs in HeLa cells in which endogenous hUpf1 was replaced with exogenous hUpf1,
hUpf1 DEAA, or hUpf1 K498A as indicated above the panels. Individual Texas-Red–labeled 50-nt probes targeting various regions of b-globin and GPx-1mRNAs
were used in (B) and (C) as indicated below images, whereas equimolar amounts of all probes were used in the experiments in (A). GFP-hDcp1a was used as a PB
marker. Merged images are displayed (RNA:red, GFP-hDcp1a:green), whereas selected enlarged regions are shown unmerged below. Percentage of cells
displaying mRNA signal in PBs is shown in the bottom right corner of images (with the number of cells counted from at least three experiments in parentheses),
and graphed for individual probes against b-39 or b-ARE mRNA below cell images, with standard deviation from three experiments, in (B). Note: plasmids that
express b-39, b-ARE, and GPx1-46 mRNAs also express GFP; thus, some nuclear staining can be observed in the green channel.
See also Figure S3.
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Figure 4. Mutant hUpf1 Proteins Deficient in ATP Binding or ATP
Hydrolysis Accumulate in PBs
Indirect immunofluorescence assays showing localization ofmyc-taggedwild-
type hUpf1, ATPase mutant (DEAA), or ATP-binding mutants (K498A, G494R,
and G496E) hUpf1 proteins transiently expressed in HeLa cells (left panels).
Human IC-6 serum, which detects the decapping factor Hedls and the nuclear
envelope component Lamin, was used as a PB marker (middle panels).
Merged images (hUpf1: green; IC-6: red) are shown in the right panels.
Enlarged images of the indicated boxed areas are shown in the upper left
corner for each image.more strongly with ATPase-deficient hUpf1 mutant proteins
than with wild-type hUpf1 in co-IP assays. In striking correlation
with the immunofluorescence assays above, the co-IP assays
in Figure 6A (lanes 1–8), in which cell extracts were not treated
with RNase, show strong enrichment of endogenous Smg5
and Smg7 and exogenous Smg6 in hUpf1 ATPase mutant
protein complexes, compared with wild-type hUpf1 complexes
(compare lanes 3 and 4 with lane 2) (see also Figure S4). Other
NMD factors, hUpf2, hUpf3b, and eIF4A3 show modestly
enhanced accumulation with hUpf1 ATPase mutant complexes
(Figure 6A), which correlates well with their moderate accu-
mulation in PBs under the same conditions (Figure 5A) (our
anti-hSmg6 and anti-hSmg1 antibodies failed to detect the
endogenous proteins on western blots). These observations
are consistent with previous observations of enhanced associa-
tion of ATP binding-deficient hUpf1 with Smg7, hUpf3a, and
hUpf2 (Kashima et al., 2006). b-actin served as a negative control
and did not copurify with wild-type or mutant hUpf1 proteins
(Figure 6A, bottom panel), and none of the endogenous NMD944 Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc.factors nonspecifically copurified with the IP resin (lane 1).
When the same assays were repeated in the presence of RNase,
Smg5 and Smg7 were the only NMD factors that remained en-
riched in the mutant hUpf1 complexes, suggesting the accumu-
lation of an RNA-independent interaction between these factors
when hUpf1 fails to hydrolyze ATP (Figure 6A, lanes 9–16). In
addition to NMD factors, both Xrn1 and PABPC1 showed
enhanced association with ATPase-deficient hUpf1 proteins
over wild-type hUpf1, although this wasmore evident in the pres-
ence than in the absence of RNase-treatment (compare lanes 11
and 12 to lane 10 and lanes 3 and 4 to lane 2). Unlike Xrn1 and
NMD factors, PABPC1 was not observed to concentrate in
PBs upon ATPase-deficient hUpf1 expression (unpublished
data), perhaps because of the high cytoplasmic abundance of
PABPC1 overwhelming detection in PBs. Taken together, these
observations are consistent with the idea that the hUpf1 ATPase
stimulates disassembly of the NMD mRNP. However, some
NMD factors show stronger accumulation than others in the
trapped mRNP complexes (Figures 5 and 6).
NMD Factors Are Associated More Strongly with the 30
NMDFragment in thePresenceofATPase-DeficientUpf1
Finally, to test whether NMD factors can be directly observed in
complex with the NMD 30 intermediate, individual NMD factors
were immunoprecipitated from cells depleted of Xrn1 and ex-
pressing the b-39 NMD substrate as well as exogenous wild-
type or ATPase-deficient hUpf1 in place of endogenous hUpf1.
As seen in the Northern blots in Figure 6B, all tested NMD
factors, EJC components, and PABPC1 are found in complex
with the 30 NMD intermediate (upper panels, band marked by
arrow). For the tested NMD factors, the association with the 30
intermediate relative to that of full-length b-39 mRNA was
enhanced 2.1–6.2-fold in the presence of ATPase-deficient
over wild-type hUpf1 (quantifications shown below blots). In
contrast, EJC components and PABPC1 showed little or no
difference in their association with the 30 fragment whether or
not hUpf1 can hydrolyze ATP (right panels). These observations
suggest that NMD factors are released from the 30 fragment by
the action of the Upf1 ATPase, whereas release of EJC compo-
nents and PABPC1 appear to require Xrn1 activity.
DISCUSSION
The Upf1 ATPase Allows NMD mRNP Disassembly
Here we have provided several lines of evidence showing that
ATP hydrolysis by Upf1 is critical for the disassembly and
completed degradation of mRNPs undergoing NMD (Figure 7).
First, mutant Upf1 proteins unable to bind or to hydrolyze ATP
cause impaired degradation of NMD substrates and accumula-
tion of a 30 intermediate (Figure 1). Second, the 30 intermediate
(Figure 2A) and multiple NMD factors (Figure 6) accumulate in
complex with Upf1 when it fails to bind or hydrolyze ATP. Third,
the NMD mRNA intermediate (Figure 3) and multiple NMD
factors (Figures 4 and 5) accumulate in PBs in the presence of
ATP binding- or ATPase-deficient mutant Upf1. The accumula-
tion of the 30 intermediate in the presence of ATPase-deficient
Upf1 is likely a result of the inability of Xrn1 to degrade the
RNA in the absence of mRNP disassembly (Figure 7). Consistent
with this, Xrn1 appears to be trapped with the NMD mRNP that
accumulates upon expression of ATPase-deficient Upf1, as
evidenced by the enhanced association of Xrn1 with Upf1
complexes and with PBs under those conditions (Figures 5A
and 6) (Cho et al., 2009; Isken et al., 2008). Moreover, the 30
NMD mRNP generated in the presence of ATPase-deficient
Upf1 is resistant to 50-to-30 exonucleolytic decay in vitro unless
protein is first removed by phenol extraction (Figure 2C). It is
unclear where on the accumulating 30 NMD mRNP that Upf1
and the NMD complex are positioned. Site-specific RNase H
cleavage followed by IP-Northern assays indicated that
ATPase-deficient Upf1 is associated with both 50 and 30 frag-
ments of the b-39 NMD 30 mRNP (unpublished data), perhaps re-
flecting interactions of Upf1 with the EJC and PABPC1 (Fig-
ure 6A) as well as directly with the RNA. On the basis of our
observations, a simple hypothesis for why NMD shuts down in
the presence of ATPase-deficient Upf1 (Figure 1A) (Kashima
et al., 2006; Weng et al., 1996a, 1996b) is that the entrapment
of NMD factors on partially degraded NMD mRNPs renders the
pathway noncatalytic as a result of the failure of NMD factor re-
cycling. Alternatively, the Upf1 ATPase could be rate-limiting for
a more upstream mRNP remodeling step, in which case the
accumulation of full-length NMD substrate and 30 intermediates
in the presence of ATPase-deficient Upf1 reflects a stronger
defect in 50-to-30 decay than in endonucleolytic cleavage. The
effect of the Upf1 ATPase on other mRNA decay activities trig-
gered by NMD, such as decapping and deadenylation, remains
to be tested. In either case, our studies illustrate the importance
of mRNP disassembly in mRNA turnover.
Although most NMD factors accumulate in PBs (Figure 5) and
in association with Upf1 (Figure 6) when Upf1 fails to hydrolyze
ATP, Smg5, Smg6, and Smg7 show stronger accumulation
than do Upf2, Upf3, and EJC proteins. These weaker associated
NMD proteins may either be more loosely associated with the
NMD mRNP intermediate, are found at lower stoichiometry in
the complex, or are found only on a subset of substrates that
require Upf1 ATPase activity for mRNP disassembly. Consistent
with the latter idea, Upf1 has been implicated independently of
Upf2 and Upf3 in the degradation of mRNAs other than NMD
substrates, including histone mRNAs (Kaygun and Marzluff,
2005) and mRNAs associated with Staufen (Kim et al., 2005).
Moreover, evidence has been presented for Upf2-, Upf3-, and
EJC-independent NMD pathways in human cells (Bu¨hler et al.,
2006; Chan et al., 2007; Gehring et al., 2005). The relatively
weak accumulation of EJC components could also be a result
of EJC disassembly by the recently discovered EJC disassembly
activity of the protein PYM (Gehring et al., 2009).
The mechanism by which the Upf1 ATPase leads to NMD
mRNP disassembly remains to be determined. Upf1 could act
as a processive RNPase that uses ATPase activity to traverse
the mRNA while displacing NMD factors and other RNA-binding
proteins from the NMD substrate (Fairman et al., 2004; Jankow-
sky and Bowers, 2006). Alternatively, Upf1 could remain
stationary and hydrolyze ATP to release itself and other associ-
ated factors from the mRNA (Ballut et al., 2005). Yet another
possibility is that ATPhydrolysis byUpf1 acts upstreamof a chain
of mRNP remodeling events that in the end lead to NMD mRNP
disassembly. The observations that Upf1 has highest affinity forRNA in the absence of ATP and shows ATP-dependent 50-to-30
RNA translocation activity in vitro (Cheng et al., 2007; Weng
et al., 1998) favor the former possibility. However, the observa-
tion that the level of NMD intermediate associated with PABPC1
and EJC components, in contrast to NMD factors, is indepen-
dent of Upf1 ATPase activity (Figure 6B), suggests that these
factors are not released directly by the Upf1 ATPase but rather
at a downstream step, perhaps by the activity of Xrn1 (Figure 7).
Either way, our observations demonstrate a previously unappre-
ciated step in mRNA decay by which mRNP disassembly allows
the completion of exonucleolytic decay and the recycling of
mRNP components. The specific mRNP components respon-
sible for blockage of exonucleolytic decay of the NMD substrate
in the presence of ATPase-deficient Upf1 remain to be deter-
mined. Possible candidates could be the NMD factors them-
selves or, perhaps, unreleased ribosomes or ribosomal subunits.
Is mRNP Disassembly a Regulated Step in NMD?
Taken together, our observations uncover a previously unappre-
ciated ATP-dependent mRNP disassembly step in mRNP
turnover. A key question is what controls the timing of mRNP
disassembly in NMD, because slow disassembly would cause
accumulation of decay intermediates whereas rapid disas-
sembly could potentially release the NMD mRNP even before it
initiates decay. The ATPase activity of human Upf1 is stimulated
by the Upf2-Upf3 complex (Chamieh et al., 2008), and the yeast
Upf1 ATPase is repressed by translation release factors eRF3
and eRF1 (Czaplinski et al., 1998). Thus, a transition in the
NMDmRNP in which Upf1 is released from eRFs and associates
with Upf2-Upf3 may precede activation of the Upf1 ATPase and
subsequent mRNP disassembly. Consistent with this, ATP
binding-deficient Upf1 has been observed to copurify less effi-
ciently than wild-type Upf1 with eRF1 and eRF3 (Czaplinski
et al., 1998; Kashima et al., 2006; Isken et al., 2008), suggesting
that it becomes trapped in a complex lacking eRFs. Moreover,
analyses of NMD complexes stalled by NMD factor mutation or
depletion have indicated a transition in the human NMD mRNP
from a complex between Upf1, Smg1, and eRFs (called SURF)
to a complex of NMD factors lacking eRFs (called DECID)
(Kashima et al., 2006). In addition, the phosphorylation and
dephosphorylation of metazoan Upf1 seems to be coordinated
with the Upf1 ATPase, because ATPase-deficient Upf1 accumu-
lates in a hyperphosphorylated form (Isken et al., 2008; Kashima
et al., 2006; Page et al., 1999), which has been reported to
prevent translation reinitiation on the NMD mRNP (Isken et al.,
2008).
Why would mRNP disassembly be under such tight control
during NMD? This could possibly ensure that NMD factors are
released only after mRNA decay factors have already been
recruited and/or mRNA decay initiated. This also raises the
possibility that ATPase-mediated mRNP disassembly could
serve as a previously proposed proofreading step in the NMD
pathway (Sheth and Parker, 2006), in which rapid hydrolysis of
ATP by Upf1 would allow the release of the NMD machinery
from the mRNA even before initiation of mRNA decay, thus
allowing mRNAs wrongly targeted for NMD to be released prior
to decay (Figure 7). Several lines of evidence suggest that the
composition of the mRNP downstream of the translationCell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc. 945
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Figure 6. Multiple NMD Factors Accumulate in
Complex with ATPase-Deficient hUpf1 and the
NMD Substrate 30 Fragment
(A) Western blots for the proteins indicated on the left
from pellet (left panels) or 2% of total extract (right panels)
fractions from anti-myc IP assays from HEK293T cells
transiently expressing proteins shown on the top, or no
exogenous protein (none). Cell extracts in lanes 9–16
were treated with RNase A prior to IP.
(B) Northern blots for b-39 mRNA isolated from pellets (IP;
top panels) or 5% total extract (Total; bottom panels)
fractions from immunoprecipitation reactions for tagged
exogenous, or in the case of hUpf2, endogenous, NMD,
EJC or PABPC1 factors, as shown on the top, in the pres-
ence of coexpressed wild-type (WT) or ATPase-deficient
(DEAA) hUpf1. Endogenous hUpf1 and Xrn1were knocked
down using siRNAs. (-) indicates a reaction using anti-HA
beads in the absence of HA-tagged protein. Anti-FLAG
and anti-Myc beads looked similar (not shown). Below
each panel is shown the calculated enrichment of the 30
fragment relative to full-length b-39 mRNA in IP pellets in
the presence of mutant hUpf1 (DEAA) over that in the
presence of wild-type hUpf1. Representative of three
independent experiments is shown.
See also Figure S4.termination event controls NMD (Amrani et al., 2006; Mu¨hle-
mann, 2008; Rebbapragada and Lykke-Andersen, 2009). A key
question for future studies is whether the downstream mRNP
controls NMD not just by NMD factor recruitment as has beenFigure 5. Multiple NMD Factors Accumulate in PBs in the Presence of ATPase-Deficien
(A and B) Indirect immunofluorescence assays showing localization in HeLa cells of endogenous NMD
NMD, HuR, in the presence of exogenously expressed hUpf1 DEAA (A) or wild-type hUpf1 (B). Middle
with a nuclear localization signal to mark transfected cells (indicated by white arrowheads). Merged im
in right panels. An enlarged cell section representing the boxed area of each image is shown in the upp
in PBs over the general cytoplasm was quantified in transfected cells and given with standard devia
Cell 143, 938–generally assumed, but also in part by regulating
the Upf1 ATPase.
Is mRNP Disassembly Critical for mRNA
Turnover Pathways Other Than NMD?
Another important question for future studies is
whether mRNP disassembly is a critical step in
mRNA decay pathways other than NMD. There
have been several observations of mRNA and
mRNP structures impairing exonucleolytic
decay. For example, in S. cerevisiae, both
50-to-30 and 30-to-50 exonucleolytic decay is
impaired by strong RNA secondary structures
(Vreken and Raue´, 1992; Decker and Parker,
1993; Muhlrad et al., 1995), and 50-to-30 exonu-
cleolytic decay is inhibited by ribosomes stalled
by cycloheximide or by rare codons (Beelman
and Parker, 1994; Cereghino et al., 1995;
Hu et al., 2009). In Caenorhabditis elegans,
50-to-30 decay intermediates of lin-41mRNA tar-
geted by let-7 microRNA have been observed
with the 50 end mapping immediately upstream
of the let-7-binding sites (Bagga et al., 2005). Even a heterolo-
gous RNA-binding protein, the MS2 coat protein, appears
capable of stalling 50-to-30 exonucleolytic decay in C. elegans
(Liu et al., 2003). In addition to exonucleolytic decay, PABPCt hUpf1
factors as indicated on the left, or a protein not involved in
panels show human IC-6 serum as a PBmarker and DsRed
ages (NMD factor: green; IC-6/NLS-DsRed: red) are shown
er left corner. The average enrichment of the protein factor
tion in each of the panels on the left.
950, December 10, 2010 ª2010 Elsevier Inc. 947
Figure 7. mRNP Disassembly during NMD
How mRNP disassembly, dependent on Upf1 ATPase activity, is required for completion of NMD and recycling of NMD factors. See Discussion for details.and the cap-binding protein, eIF4E, can inhibit initiation of mRNA
decay by deadenylation and decapping, respectively (Schwartz
and Parker, 2000; Tucker et al., 2002). Thus, disassembly of the
mRNP is likely to be a critical step in both the initiation and
the completion of mRNA turnover. Future studies should reveal
the extent to which helicases are involved in these processes.
Several helicase proteins have been identified in association
with mRNA decay enzymes, including Rck/p54 of the decapping
complex and Ski2 of the exosome (Anderson and Parker, 1998;
Coller et al., 2001; Fischer and Weis, 2002; Fenger-Grøn et al.,
2005), as well as in association with bacterial and mitochondrial
exonucleases (Carpousis, 2007). Future studies should reveal
whether such helicases are important for mRNP disassembly
to allow for processivity of their associated mRNA decay
enzymes, and whether pathway-specific mRNP disassembly
factors are common in mRNA turnover pathways in addition to
NMD.EXPERIMENTAL PROCEDURES
mRNA Decay and RNA Immunoprecipitation Assays
Expression of NMD reporter b-39 or GPx1-46 mRNAs was induced for 6 hr by
incubation in tetracycline-free medium of HeLa Tet-off cells, depleted of
endogenous hUpf1 and/or Xrn1 using siRNAs, and transiently transfected
with plasmids expressing tetracycline-regulated b-39 or GPx1-46 mRNAs,
and constitutively expressed control b-GAP mRNAs (Figure 1 only), as well
as plasmids expressing siRNA-resistant wild-type or mutant (DEAA or
K498A) hUpf1 protein, and in Figure 6B, other tagged NMD factors as indi-
cated (see Extended Experimental Procedures for details). In endogenous
mRNA decay assays (Figure 1), total RNA was prepared from cells using Trizol
reagent (Invitrogen), 0, 2, 4, or 6 hr after addition of 1 mg/ml tetracycline to
repress NMD reporter mRNA transcription. In in vitro decay assays mediated
by Terminator (Figure 2C), cell extracts prepared in hypotonic gentle lysis
buffer, or total RNA prepared from extracts using Trizol, were incubated with
Terminator 50-to-30 exonuclease (Epicenter) for 0, 5, 10, 20 or 40 min followed
by RNA preparation using Trizol. In RNA-immunoprecipitation assays (Figures
2A and 2B and Figure 6B), cell extracts prepared in isotonic lysis buffer were948 Cell 143, 938–950, December 10, 2010 ª2010 Elsevier Inc.subjected to immunoprecipitation against the indicated NMD factors, and
RNA from immunoprecipitated samples was isolated using Trizol. NMD
substrate levels were analyzed by Northern blotting.
Indirect Immunofluorescence and Fluorescence
In Situ Hybridization Assays
Human HeLa cells transiently expressing wild-type or mutant myc-tagged
hUpf1 proteins were fixed with formaldehyde and permeabilized with Triton
X-100 (Figures 4 and 5) or ethanol (Figure 3). For indirect immunofluorescence
assays, cells were incubated with antibodies against Myc-tag (Figure 4) or
against endogenous NMD factors, Xrn1 or HuR (Figure 5), as well as with
human IC-6 serum, which recognizes endogenous Hedls (P body marker)
and Lamin, followed by fluorescently labeled secondary antibodies (anti-
mouse or –rabbit, Alexa 488; anti-human, Texas Red). Cells in Figure 5 express
nuclear DsRed to mark transfected cells. For fluorescence in situ hybridization
(FISH) assays, cells were hybridized with a mixture of (Figures 3A and 3C), or
individual (Figure 3B), TexasRed-50-labeled 50-nucleotide NMD substrate
mRNA antisense DNA probes. Cells for FISH assays express GFP-tagged
hDcp1a to mark P bodies (see Extended Experimental Procedures for details).
Coimmunoprecipitation Assays
Lysates from HEK293T cells transiently expressing Myc-tagged wild-type or
mutant (DEAA or K498A) hUpf1 were subjected, in the presence or absence
of RNase A, to anti-Myc immunoprecipitation followed by Western blotting
for endogenous NMD factors, Xrn1, PABPC1, or b-actin, or in the case of
Smg6, coexpressed HA-tagged Smg6.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cell.2010.11.043.
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